Search research articles
Contact Us
Filters
Showing results (61-70 of 193) with videos related to
Page
of 20
Sort By:
Infectious Diseases and Therapy
|
October 14, 2021
Contemporary Perspective on the Treatment of Acinetobacter baumannii Infections: Insights from the Society of Infectious Diseases Pharmacists
Jacinda C Abdul-Mutakabbir, Nicole C Griffith, Ryan K Shields, et al.
The Journal of Antimicrobial Chemotherapy
|
February 2, 2026
Evaluating hypoalbuminaemia thresholds associated with delayed blood sterilization among patients receiving cefazolin or antistaphylococcal penicillins for MSSA bacteraemia
Sunish Shah, Lingyi Peng, Lloyd G Clarke, et al.
The Journal of Antimicrobial Chemotherapy
|
May 31, 2025
Impact of hypoalbuminemia on patients receiving ertapenem combination therapy for methicillin-susceptible Staphylococcus aureus bacteraemia
Sunish Shah, Lloyd G Clarke, G K Balasubramani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 11, 2022
Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase-Producing Pathogens in the CREDIBLE-CR and APEKS-NP Phase 3 Randomized Studies
Jean Francois Timsit, Mical Paul, Ryan K Shields, et al.
Antimicrobial Agents and Chemotherapy
|
October 10, 2025
<i>In vitro</i> evolution of durlobactam resistance in NDM-producing <i>Escherichia coli</i> due to a single mutation in <i>mrdA</i> encoding penicillin-binding protein 2
Christi L McElheny, Erika L Butcher, Akito Kawai, et al.
Open Forum Infectious Diseases
|
August 21, 2023
Impact of Rapid Identification and Stewardship Intervention on Coagulase-Negative <i>Staphylococcus</i> Bloodstream Infection
Eli S Goshorn, J Alex Viehman, J Ryan Bariola, et al.
Open Forum Infectious Diseases
|
July 8, 2017
Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in <i>Klebsiella pneumoniae</i> Carbapenemase-Producing <i>K pneumoniae</i>: A Case Report and Review of Literature
Ryan K Shields, M Hong Nguyen, Ellen G Press, et al.
Msphere
|
December 4, 2025
Allele-specific effects of mutations in the rifampin resistance-determining region (RRDR) of RpoB on physiology and antibiotic resistance in <i>Enterococcus faecium</i>
Adeline Supandy, Emma G Mills, Kyong T Fam, et al.
Open Forum Infectious Diseases
|
January 7, 2021
Plasma and Cerebrospinal Fluid Therapeutic Drug Monitoring of Ceftolozane and Tazobactam During Treatment of Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Meningitis
Erin K McCreary, Karin E Byers, Carolyn Fernandes, et al.
Jac-Antimicrobial Resistance
|
June 30, 2025
Comparative <i>in vitro</i> activity of sulbactam with avibactam or durlobactam against carbapenem-resistant <i>Acinetobacter baumannii</i>
Ava J Dorazio, Ellen G Kline, Kevin M Squires, et al.
Page
of 20
Search research articles
Search
Showing results (61-70 of 193) with videos related to
Sort By:
Page
of 20
Infectious Diseases and Therapy
|
October 14, 2021
Contemporary Perspective on the Treatment of Acinetobacter baumannii Infections: Insights from the Society of Infectious Diseases Pharmacists
Jacinda C Abdul-Mutakabbir, Nicole C Griffith, Ryan K Shields, et al.
The Journal of Antimicrobial Chemotherapy
|
February 2, 2026
Evaluating hypoalbuminaemia thresholds associated with delayed blood sterilization among patients receiving cefazolin or antistaphylococcal penicillins for MSSA bacteraemia
Sunish Shah, Lingyi Peng, Lloyd G Clarke, et al.
The Journal of Antimicrobial Chemotherapy
|
May 31, 2025
Impact of hypoalbuminemia on patients receiving ertapenem combination therapy for methicillin-susceptible Staphylococcus aureus bacteraemia
Sunish Shah, Lloyd G Clarke, G K Balasubramani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 11, 2022
Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase-Producing Pathogens in the CREDIBLE-CR and APEKS-NP Phase 3 Randomized Studies
Jean Francois Timsit, Mical Paul, Ryan K Shields, et al.
Antimicrobial Agents and Chemotherapy
|
October 10, 2025
<i>In vitro</i> evolution of durlobactam resistance in NDM-producing <i>Escherichia coli</i> due to a single mutation in <i>mrdA</i> encoding penicillin-binding protein 2
Christi L McElheny, Erika L Butcher, Akito Kawai, et al.
Open Forum Infectious Diseases
|
August 21, 2023
Impact of Rapid Identification and Stewardship Intervention on Coagulase-Negative <i>Staphylococcus</i> Bloodstream Infection
Eli S Goshorn, J Alex Viehman, J Ryan Bariola, et al.
Open Forum Infectious Diseases
|
July 8, 2017
Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in <i>Klebsiella pneumoniae</i> Carbapenemase-Producing <i>K pneumoniae</i>: A Case Report and Review of Literature
Ryan K Shields, M Hong Nguyen, Ellen G Press, et al.
Msphere
|
December 4, 2025
Allele-specific effects of mutations in the rifampin resistance-determining region (RRDR) of RpoB on physiology and antibiotic resistance in <i>Enterococcus faecium</i>
Adeline Supandy, Emma G Mills, Kyong T Fam, et al.
Open Forum Infectious Diseases
|
January 7, 2021
Plasma and Cerebrospinal Fluid Therapeutic Drug Monitoring of Ceftolozane and Tazobactam During Treatment of Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Meningitis
Erin K McCreary, Karin E Byers, Carolyn Fernandes, et al.
Jac-Antimicrobial Resistance
|
June 30, 2025
Comparative <i>in vitro</i> activity of sulbactam with avibactam or durlobactam against carbapenem-resistant <i>Acinetobacter baumannii</i>
Ava J Dorazio, Ellen G Kline, Kevin M Squires, et al.
Page
of 20